Factors affecting visual loss in benign intracranial hypertension
- PMID: 6514295
- DOI: 10.1016/s0161-6420(84)34149-5
Factors affecting visual loss in benign intracranial hypertension
Abstract
Visual function and optic disc appearances were studied in 68 patients conforming to established criteria of benign intracranial hypertension (BIH). The clinical, radiological, and laboratory findings of those patients whose visual field or acuity deteriorated were compared with those who did not deteriorate over an average follow-up of 4.1 years. Definite loss of visual function occurred in 49% of eyes and was severe in 6%. Patients with high grade or atrophic papilledema, or peripapillary subretinal hemorrhage, were significantly more likely to have had deterioration of visual function. Transient obscurations of vision and the presence of optico-ciliary shunts were associated with severe visual loss. Anemia, older age, and high myopia were other risk factors for visual loss. Chronic papilledema may cause progressive visual loss and, for this reason, BIH is not a benign condition; fundal changes and visual function should be carefully monitored.
Similar articles
-
Unilateral papilledema in 'benign' intracranial hypertension (pseudotumor cerebri).JAMA. 1983 Nov 4;250(17):2346-7. JAMA. 1983. PMID: 6632132
-
Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.Br J Ophthalmol. 2016 Apr;100(4):505-9. doi: 10.1136/bjophthalmol-2015-307043. Epub 2015 Aug 12. Br J Ophthalmol. 2016. PMID: 26269534
-
Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri.Neurosurgery. 1992 Mar;30(3):391-5. doi: 10.1227/00006123-199203000-00013. Neurosurgery. 1992. PMID: 1620303
-
Management of benign intracranial hypertension (pseudotumor cerebri).Clin Neurosurg. 1968;15:161-74. doi: 10.1093/neurosurgery/15.cn_suppl_1.161. Clin Neurosurg. 1968. PMID: 4256644 Review. No abstract available.
-
Update on Idiopathic Intracranial Hypertension.Neurol Clin. 2017 Feb;35(1):45-57. doi: 10.1016/j.ncl.2016.08.004. Neurol Clin. 2017. PMID: 27886895 Free PMC article. Review.
Cited by
-
Advantages and Pitfalls of the Use of Optical Coherence Tomography for Papilledema.Curr Neurol Neurosci Rep. 2024 Mar;24(3):55-64. doi: 10.1007/s11910-023-01327-6. Epub 2024 Jan 23. Curr Neurol Neurosci Rep. 2024. PMID: 38261144 Review.
-
Clinical and demographic differences between idiopathic intracranial hypertension patients with mild and severe papilledema.Taiwan J Ophthalmol. 2020 Oct 7;11(1):53-56. doi: 10.4103/tjo.tjo_44_20. eCollection 2021 Jan-Mar. Taiwan J Ophthalmol. 2020. PMID: 33767955 Free PMC article.
-
Course and Predictors of Visual Outcome of Idiopathic Intracranial Hypertension.Neuroophthalmology. 2021 Oct 13;46(2):80-84. doi: 10.1080/01658107.2021.1984540. eCollection 2022. Neuroophthalmology. 2021. PMID: 35273409 Free PMC article.
-
Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure.J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1426-9. doi: 10.1136/jnnp.57.11.1426. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964827 Free PMC article.
-
Racial differences in idiopathic intracranial hypertension.Neurology. 2008 Mar 11;70(11):861-7. doi: 10.1212/01.wnl.0000304746.92913.dc. Neurology. 2008. PMID: 18332344 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical